| Mepha Pharma AG - Buprenorphin-Mepha 0.4 mg, Sublingualtabletten |
| 65188 | | 01 | | Buprenorphin-Mepha 0.4 mg | | Sublingualtabletten | | N07BC01 | | Buprenorphine | | 12.12.2014 | | |
|
| Composition |
| buprenorphinum 0.4 mg ut buprenorphini hydrochloridum 0.43 mg, magnesii stearas, natrii citras anhydricus corresp. natrium 0.144 mg, povidonum K 29-32, acidum citricum, amylum pregelificatum, lactosum monohydricum 63.6 mg, pro compresso. |
| Packungsbestandteile |
| Sublingual tablets | | | | | Active Agent | Dose |
|---|
| Buprenorphine | 0.4 mg |
| | BAG: Active Agent | Dose |
|---|
| Buprenorphine | 0.4 mg |
| | | | Inactive agents | Dose |
|---|
| Citric Acid | | | Amylum Pregelificatum | | | Lactose Monohydrate | 63.6 mg | | Magnesii Stearas | | | Natrii Citras Anhydricus | | | Povidonum K | 29-32 | | Pro Compresso | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 7 Tablet(s) | 2.38 | 11.80 | A+ | SL | No | | 002 | 28 Tablet(s) | | | A+ | | No |
|
